Pinjia Liu
- Topics
- MicroRNA in disease regulation (1 paper)RNA modifications and cancer (1 paper)SARS-CoV-2 and COVID-19 Research (1 paper)
- Journals
- Molecular CancerReviews in Medical VirologyAdvances in Microbiology
- Partner nations
- ChinaUnited States
In The Last Decade
Pinjia Liu
3 papers receiving 165 citations
Hit Papers
Peers
Comparison fields: 5 of 37
- Molecular Biology 141
- Cancer Research 107
- Infectious Diseases 13
- Oncology 12
- Epidemiology 8
Countries citing papers authored by Pinjia Liu
This map shows the geographic impact of Pinjia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinjia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinjia Liu more than expected).
Fields of papers citing papers by Pinjia Liu
This network shows the impact of papers produced by Pinjia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinjia Liu. The network helps show where Pinjia Liu may publish in the future.
Co-authorship network of co-authors of Pinjia Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Pinjia Liu. A scholar is included among the top collaborators of Pinjia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinjia Liu. Pinjia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinomabreakdown → | 145 |
| 2 | 1 | |
| 3 | 19 |
About Pinjia Liu
Pinjia Liu is a scholar working on Cancer Research, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 3 papers that have together received 165 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (1 paper), RNA modifications and cancer (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Cancer Research (107 citations), Molecular Biology (141 citations) and Infectious Diseases (13 citations). Pinjia Liu has collaborated with scholars based in China and United States. Frequent co-authors include Aroona Razzaq, Ashuai Du, Zijun Dong, Yuzheng Zhou, Zanxian Xia, Cyrollah Disoma, Shiqin Li, Yuxin Liu, Shanni Li and Sixu Liu. Their work appears in journals such as Molecular Cancer, Reviews in Medical Virology and Advances in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.